Guido Grandi, Segrate ( Mi) IT
Guido Grandi, Segrate ( Mi) IT
Patent application number | Description | Published |
---|---|---|
20090025098 | Hepatitis C receptor protein CD81 - The present invention relates to the use of CD81 protein and polynucleic acid in the therapy and diagnosis of hepatitis C and pharmaceutical compositions, animal models and diagnostic kits for such purposes. | 01-22-2009 |
20130071416 | IMMUNOGENIC PROTEINS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF STREPTOCOCCUS AGALACTIAE - The invention provides proteins and compositions for the treatment and prevention of | 03-21-2013 |
20130129740 | NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A AND B - The invention provides proteins from group B | 05-23-2013 |
20130171238 | IMMUNOGENIC COMPOSITIONS FOR CHLAMYDIA TRACHOMATIS - The invention relates to immunogenic compositions comprising combinations of | 07-04-2013 |
20130202609 | GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES - The invention provides mutants of GAS57 (Spy0416) which are unable to cleave IL-8 and similar substrates but which still maintain the ability to induce protection against | 08-08-2013 |
20140004140 | GROUP B STREPTOCOCCUS VACCINE | 01-02-2014 |
20140037671 | IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS PYOGENES - The invention includes a GAS antigen, GAS 40, which is particularly suitable for use either alone or in combinations with additional GAS antigens, such as GAS 117, GAS 130, GAS 277, GAS 236, GAS 40, GAS 389, GAS 504, GAS 509, GAS 366, GAS 159, GAS 217, GAS 309, GAS 372, GAS 039, GAS 042, GAS 058, GAS 290, GAS 511, GAS 533, GAS 527, GAS 294, GAS 253, GAS 529, GAS 045, GAS 095, GAS 193, GAS 137, GAS 084, GAS 384, GAS 202, and GAS 057. | 02-06-2014 |
20150030625 | GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES - The invention provides mutants of GAS57 (Spy0416) which are unable to cleave IL-8 and similar substrates but which still maintain the ability to induce protection against | 01-29-2015 |